Viridian Therapeutics Inc (VRDN) Annual Income Statement (USD)
VRDN Quarterly Financials (USD)
Frequently Asked Questions About Viridian Therapeutics Inc (VRDN) Stock
Viridian Therapeutics Inc's (VRDN) last reported annual revenue was USD 314000.00.
Viridian Therapeutics Inc's (VRDN) annual revenue growth rate based on the revenue reported in the past 5 years is : -48.16%
Viridian Therapeutics Inc's(VRDN) is not profitable as of its last reported annual financials.
The net profit margin for Viridian Therapeutics Inc's(VRDN) from its laster reported year is -75711.46%
The return on equity (ROE) for Viridian Therapeutics Inc's(VRDN) from its last reported annual financials is : -56.80%
The return on assets (ROA) for Viridian Therapeutics Inc's(VRDN) from its last reported annual financials is : -34.37%
The return on invested capital (ROIC) for Viridian Therapeutics Inc's(VRDN) from its last reported annual financials is : -63.35%
The Debt to Equity ratio for Viridian Therapeutics Inc's(VRDN) from its last reported annual financials is : 4.57%
The dividend yield for Viridian Therapeutics Inc's(VRDN) from its laster reported year is 0.00%
Viridian Therapeutics Inc's(VRDN) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for VRDN !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
